November 13, 2019

MGC Pharma Receives First Government Grant for Clinical Trial

MGC Pharma announced it's received government funding for its clinical trial with the University of Notre Dame Western Australia.
November 5, 2019

MGC Pharma Posts Quarterly Update

MGC Pharmaceuticals shared with investors its financial report for its most recent quarter.
October 31, 2019

MGC Pharmaceuticals Reports Update on LSE Listing

MGC Pharmaceuticals announced an increase in patient numbers and reported progress on its LSE listing in its September quarterly report.
October 30, 2019

MGC Pharmaceuticals Sets Date for Annual General Meeting

MGC Pharmaceuticals issued a notice for its annual general meeting set to take place on November 29, 2019.
October 29, 2019

MGC Pharmaceuticals Reaches 800 Patients in Australia and UK

MGC Pharmaceuticals, a cannabinoid medicines maker, has passed 800 patients with prescriptions of its products in Australia and the UK.